A Study of ARRY-371797 in Patients With Rheumatoid Arthritis

Summary

This is a Phase 1 study, involving a 29-day treatment period, designed to evaluate the pharmacokinetics and the effectiveness of investigational study drug ARRY-371797 in treating rheumatoid arthritis in patients receiving stable doses of methotrexate, and to further evaluate the drug's safety. Approximately 30 patients from the US will be enrolled in this study.

Timeline

Start

2008-07

Primary completion

2009-04

Completion

2009-04

Drugs

Indications